Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04815707 · ClinicalTrials.gov registry record · Phase 2
Treatment of Occult Inguinal Hernias
A Phase 2 study of Inguinal Hernia, sponsored by The University of Texas Health Science Center, Houston.
- Active
- Registry status
- Phase 2
- Development phase
- 252
- Enrollment target
- 2
- Study locations
NCT04815707: Active Phase 2 study of Inguinal Hernia, sponsored by The University of Texas Health Science Center, Houston.
NCT04815707 is a Phase 2 study of Inguinal Hernia that is active but no longer recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 252 participants, below the 334-participant average among 11 other Inguinal Hernia trials with a reported enrollment target (25% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04815707, a Phase 2 study of Inguinal Hernia, is active but no longer recruiting, sponsored by The University of Texas Health Science Center, Houston.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 252 participants
- Enrollment target
- 2
- Study locations
Study Summary
Inguinal hernias are a common surgical problem. Best management of occult inguinal hernias, defined as hernias unable to be felt on physical exam, is unknown. From prior studies we know that most inguinal hernias will eventually become symptomatic and require surgery (70%). However, doing a repair on a very small, occult hernia may open the patient up to surgical complications, like chronic pain, earlier than necessary. This will be a multi-center randomized controlled trial of surgical repair versus expectant management of occult inguinal hernias. Patients undergoing laparoscopic unilateral inguinal hernia repair will be included. At the time of surgery, the surgeon will determine if there is an occult hernia contralateral side. If present, patients will be randomized to repair of the occult side or expectant management of the occult side. After 1 year post-operative data has been assessed, a decision tool will be created and administered to patients to aid in their decision making about treatments for their hernia.
Primary Outcome
Assessed by using a decision tool (standard gamble method) that will be developed using information gathered at 1 year post-operative
Conditions Studied
Interventions
- PROCEDURE Occcult hernia repair
Study Locations (2)
Texas
- Lyndon B. Johnson General Hospital - Houston
- Memorial Hermann Hospital-MIST Clinics - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2021-10-22 |
| Est. Completion | 2026-10 |
| Phase | Phase 2 |
What the registry record for NCT04815707 still lists
NCT04815707 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 334-participant average among 11 other Inguinal Hernia trials with a reported enrollment target (25% lower).
The record links to 1 condition, with Inguinal Hernia appearing as the primary indexed condition, and to 1 intervention - of which Occcult hernia repair is the first listed.
NCT04815707 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04815707 about?
NCT04815707 is a clinical study titled "Treatment of Occult Inguinal Hernias". Inguinal hernias are a common surgical problem. Best management of occult inguinal hernias, defined as hernias unable to be felt on physical exam, is unknown. From prior studies we know that most inguinal hernias will eventually become symptomatic and require surgery (70%). However, doing a repair o...
What is the current status of trial NCT04815707?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 252 participants. The study started on 2021-10-22. Estimated completion is 2026-10.
What conditions does trial NCT04815707 study?
This clinical trial studies the following conditions: Inguinal Hernia.
What interventions are being tested in trial NCT04815707?
The interventions under investigation include: Occcult hernia repair (PROCEDURE).
Who is sponsoring clinical trial NCT04815707?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04815707 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inguinal Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04815707's enrollment target sits among peer trials
252 4th of 11 higher than 8 of 11 other Inguinal Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inguinal Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Pilot Study of Local Anesthesia for Inguinal Hernia Surgery in Older Adults
RECRUITING · NA
-
Activity Restrictions After Inguinal Hernia Repair
RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs
ACTIVE NOT RECRUITING · Early Phase 1
-
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
ACTIVE NOT RECRUITING · Phase 4
-
Methocarbamol in Ventral and Inguinal HR
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI